Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2000
12/07/2000WO2000041681A3 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000WO2000037141A9 Combination chemotherapy
12/07/2000WO2000024390A9 Method and composition for modulating amyloidosis
12/07/2000DE19925613A1 Verbundlaminat und Verfahren zu seiner Herstellung A composite laminate and method of production
12/07/2000DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19924892A1 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375850A1 Method and compositions relating to insulin resistance disorders
12/07/2000CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000CA2375666A1 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000CA2375633A1 Cranberry seed oil extract and compositions containing components thereof
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375237A1 Method of sterilizing
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374946A1 Balsam for the treatment of surface burns and chafing rashes
12/07/2000CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000CA2374310A1 Nutritional supplements
12/07/2000CA2374288A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2374129A1 Therapeutic use of melatonin
12/07/2000CA2374119A1 Method and composition for masking mineral taste
12/07/2000CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000CA2370364A1 Sunscreen composition containing sol-gel microcapsules
12/07/2000CA2368192A1 Preparations for the application of antiseptic agents to the interior of the human or animal body
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1058117A1 Use of SLIM3 to bind to molecules
12/06/2000EP1057491A1 Preventives/remedies for skin aging
12/06/2000EP1057487A1 Antimicrobial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith
12/06/2000EP1057483A1 Composition comprising theanine
12/06/2000EP1057480A2 Transdermal estrogen agonist-antagonist therapy
12/06/2000EP1057033A1 Treating cancer
12/06/2000EP1057032A2 Treating cancer
12/06/2000EP1057031A1 Treating cancer
12/06/2000EP1057030A2 Treating cancer
12/06/2000EP1057029A2 Treating cancer
12/06/2000EP1057028A1 Treating cancer
12/06/2000EP1057027A2 Treating cancer
12/06/2000EP1056886A1 Hla linked pre-eclampsia and miscarriage susceptibility gene
12/06/2000EP1056871A1 Cprot03, a human cysteine protease
12/06/2000EP1056854A2 Protease-activated receptor 4 and uses thereof
12/06/2000EP1056853A2 Human channel-related molecules
12/06/2000EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056770A1 Novel disulfides and thiol compounds
12/06/2000EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE
12/06/2000EP1056476A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
12/06/2000EP1056473A1 Targeted delivery of biologically active media
12/06/2000EP1056471A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
12/06/2000EP1056469A1 Novel peptide copolymer compositions
12/06/2000EP1056467A2 Method for the treatment of diseases or disorders of the inner ear
12/06/2000EP1056450A1 Farnesyl-protein transferase inhibitors
12/06/2000EP1056449A2 20-hete antagonists and agonists
12/06/2000EP1056448A1 Pharmaceutical combinations containing tramadol
12/06/2000EP1056442A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
12/06/2000CN1275917A Potentiator for antibody against lymphoid tumor
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1275909A In-modulators
12/06/2000CN1275908A Preparation of directly mouldable tabletting auxiliary
12/06/2000CN1275885A Precise efficary assay methods for active agents including chemotherapeutic agents
12/06/2000CN1275404A Anticancer medicine composition
12/05/2000US6156799 Method of increasing bone volume using non-naturally-occurring FP selective agonists
12/05/2000US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/05/2000US6156773 Pharmaceutical composition
12/05/2000US6156772 Indole hormone inhibitors
12/05/2000US6156770 Antiviral agents, bactericides, antitumor agents and antihistamines
12/05/2000US6156753 Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
12/05/2000US6156742 Emergency contraceptive kit
12/05/2000US6156525 Method for judging eradication of H. pylori based on rates of changes in the pepsinogen I/II ratio
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000US6156516 Method for screening substance inhibiting activation of NF-κB
12/05/2000US6156332 Method and composition for masking mineral taste
12/05/2000US6156321 Tissue factor methods and compositions for coagulation and tumor treatment
12/05/2000US6156312 Administering calcium antagonist and drug that reduces ratio of adenosine phosphate to guanosine phosphate
12/05/2000US6156310 Isolated polypeptide
12/05/2000US6156294 Composition and method for treatment of otitis media
12/05/2000US6155266 Stimulating the production of natural killer cells to destroy tumor cells by administering interferons and a histamine receptors agonist
12/05/2000CA2195974C 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
12/05/2000CA2135179C Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
12/03/2000CA2281430A1 Skin care compositions and their use in healing injured skin
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000072023A2 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000072015A2 Diagnostics and therapeutics for cardiovascular disorders
11/30/2000WO2000072008A2 Identification of novel mechanisms of drug resistance
11/30/2000WO2000071753A2 Diagnostics and therapeutics for restenosis
11/30/2000WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071717A1 Secreted alpha-helical protein - 32
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 1151